According to a newly published market research report by 24LifeSciences, global Hepatitis B and C Diagnostics market was valued at USD 3.8 billion in 2024 and is projected to reach USD 5.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period 2025-2031.
Hepatitis B diagnostic tests analyze blood samples for HBV antigens/antibodies (HBsAg, anti-HBc,...
"Executive Summary Infectious Disease Diagnostics Market Research: Share and Size Intelligence
The credible Infectious Disease Diagnostics report has estimations of CAGR values, which are very important for businesses in deciding upon the investment value over the time period. The report brings into focus studies about market definition, market segmentation, and competitive analysis...
"In-Depth Study on Executive Summary North America Infectious Disease Diagnostics Market Size and Share
The North America infectious disease diagnostics market size was valued at USD 8.98 billion in 2025 and is expected to reach USD 15.39 billion by 2033, at a CAGR of 6.90% during the forecast periodThe market growth is largely fueled by the increasing prevalence of infectious...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek